Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin

Jay M. Margolis; Steven Deitelzweig; Jeffrey Kline; Oth Tran; David M. Smith; Concetta Crivera; Brahim Bookhart; Jeff Schein

首页> 外文期刊>Clinical therapeutics >Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin

【24h】

Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin

机译：用Rivaroxaban治疗的肺栓塞住院患者与华法林相比，较短的医院住宿和降低成本

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical therapeutics》 |2016年第11期|共8页
作者
Jay M. Margolis; Steven Deitelzweig; Jeffrey Kline; Oth Tran; David M. Smith; Concetta Crivera; Brahim Bookhart; Jeff Schein;
展开▼
作者单位

Truven Health Analytics Bala Cynwyd Pennsylvania;

Ochsner Health System and The University of Queensland School of Medicine Ochsner Clinical School;

Carolinas Medical Center Indianapolis Indiana;

Truven Health Analytics Bethesda Maryland;

Truven Health Analytics Bethesda Maryland;

Janssen Scientific Affairs LLC Raritan New Jersey;

Janssen Scientific Affairs LLC Raritan New Jersey;

Janssen Scientific Affairs LLC Raritan New Jersey;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin [J] . Jay M. Margolis, Steven Deitelzweig, Jeffrey Kline, Clinical therapeutics . 2016,第11期

机译：用Rivaroxaban治疗的肺栓塞住院患者与华法林相比，较短的医院住宿和降低成本
2. Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism? [J] . Coleman Craig I., Fermann Gregory J., Weeda Erin R., Clinical and applied thrombosis/hemostasis . 2017,第7期

机译：Rivaroxaban是否与较短的医院保持并降低成本与患有肺栓塞患者患者的肠胃外桥接，而肠胃外桥接？
3. Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation? [J] . Fran?ois Laliberté, Dominic Pilon, Monika K Raut, Current medical research and opinion . 2014,第4期

机译：住院时间：利伐沙班与非瓣膜性房颤患者相比华法林住院时间短吗？
4. Role of Direct Cost in Unit Cost Based on Activity-Based Costing in the Inpatient Room of the MS General Hospital [C] . Nuryadi, Widodo J. Pudjirahardjo International Symposium on Health Research;National Congress of The Indonesian Public Health Association . 2020

机译：基于MS综合医院住院房间的基于活动的成本直接成本的直接成本的作用
5. Staphylococcus Aureus Infections: Impact on Cost, Length of Stay and Mortality at Hospitals in Louisiana: An analysis of the 2000-2007 Louisiana Hospital Inpatient Discharge Data. [D] . Jones-Nazar, Catrin. 2011

机译：金黄色葡萄球菌感染：对路易斯安那州医院的费用，住院时间和死亡率的影响：对2000-2007年路易斯安那州医院住院病人出院数据的分析。
6. Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions [O] . Jay M. Margolis, Steven Deitelzweig, Jeffrey Kline, 2016

机译：与华法林相比利伐沙班的住院时间更短费用更低静脉血栓形成的入院率更高
7. Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin [O] . Margolis Jay M., Deitelzweig Steven, Kline Jeffrey, 2016

机译：与华法林相比，接受利伐沙班治疗的肺栓塞住院患者住院时间更短，费用更低
8. Comparative Study of the Lengths of Stay of Matched Groups of Inpatients Treated in Civilian, United States Army, Navy, and Air Force Hospitals. [R] . Maxwell, W. K. 1974

机译：平民，美国陆军，海军和空军医院治疗住院患者住院时间的比较研究。

Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin

著录项

相似文献

相关主题

期刊订阅